Resuscitative EndoVascular Aortic Occlusion for Maximal Perfusion (REVAMP)
The Use of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) as an Adjunct to Advanced Cardiac Life Support in Non-traumatic Cardiac Arrest: an Early Feasibility Trial
Sponsor: Yale University
A EARLY_PHASE1 clinical study on Cardiac Arrest, this trial is completed. The trial is conducted by Yale University and has accumulated 11 data snapshots since 2020. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Sep 2021 — Jul 2024 [monthly]
Completed EARLY_PHASE1
Status: Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Recruiting EARLY_PHASE1
-
Dec 2020 — Jan 2021 [monthly]
Recruiting EARLY_PHASE1
Status: Active Not Recruiting → Recruiting
▶ Show 6 earlier versions
-
Nov 2020 — Dec 2020 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Apr 2020 — Nov 2020 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Recruiting → Active Not Recruiting
-
Feb 2020 — Apr 2020 [monthly]
Recruiting EARLY_PHASE1
-
Jan 2020 — Feb 2020 [monthly]
Recruiting EARLY_PHASE1
-
Feb 2019 — Jan 2020 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Nov 2018 — Feb 2019 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .